Nephros, Inc. (NASDAQ:NEPH) Short Interest Update

Nephros, Inc. (NASDAQ:NEPH) was the target of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 9,600 shares, a growth of 92.0% from the January 31st total of 5,000 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average trading volume of 13,200 shares, the days-to-cover ratio is presently 0.7 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC purchased a new stake in Nephros, Inc. (NASDAQ:NEPH) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned approximately 3.98% of Nephros at the end of the most recent reporting period. 41.10% of the stock is owned by institutional investors and hedge funds.

Nephros Stock Performance

NEPH traded down $0.09 during midday trading on Friday, reaching $1.51. 3,304 shares of the company were exchanged, compared to its average volume of 14,833. The stock has a market capitalization of $15.92 million, a P/E ratio of -16.78 and a beta of 1.19. The stock’s 50-day simple moving average is $1.55 and its 200 day simple moving average is $1.61. Nephros has a one year low of $1.36 and a one year high of $3.26.

Analysts Set New Price Targets

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $5.00 target price on shares of Nephros in a research note on Tuesday, November 12th.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.